Tuesday, July 29, 2014         

 Print   Email   Comment | View 5 Comments   Most Popular   Save   Post   Retweet

Hawaii to receive $1.2M in Advair settlement

By Erika Engle

LAST UPDATED: 07:30 a.m. HST, Jun 04, 2014

Pharmaceutical manufacturer GlaxoSmithKline LLC has agreed to pay the state of Hawaii $1.2 million, as part of a $105 million settlement with 43 other states and the District of Columbia, over allegedly illegal promotion of asthma drug Advair, as well as antidepressant drugs Paxil and Wellbutrin.

"While we are certain this will put a stop to the off-label use of these drugs, we will be keeping a close eye on how the company proceeds forward in its business practices," said Bruce Kim, executive director of the state Office of Consumer Protection, in a statement. "Patients need to feel safe in the way their health is being treated. Profit cannot be the motivation for these decisions." 

A state court judgment also requires GSK to reform its marketing and promotional practices.

 Print   Email   Comment | View 5 Comments   Most Popular   Save   Post   Retweet

You must be subscribed to participate in discussions
By participating in online discussions you acknowledge that you have agreed to the TERMS OF SERVICE. An insightful discussion of ideas and viewpoints is encouraged, but comments must be civil and in good taste, with no personal attacks. Because only subscribers are allowed to comment, we have your personal information and are able to contact you. If your comments are inappropriate, you may receive a warning, and if you persist with such comments you may be banned from posting. To report comments that you believe do not follow our guidelines, email commentfeedback@staradvertiser.com.
Leave a comment

Please login to leave a comment.
entrkn wrote:
Are residents with COPD that are using prescribed Advair entitled to any part of this settlement?
on June 4,2014 | 10:36AM
ryan02 wrote:
I doubt it. If the reason for the State settlement is similar to the federal one, then the problem is that Advair was being pushed for use by mild asthma sufferers who didn't really need it. I think people with COPD legitimately need Advair, so that wouldn't have been part of the lawsuit. Just my 2 cents. I suppose someone can research the lawsuit to verify.
on June 4,2014 | 12:48PM
bullturd wrote:
NO! If the medication caused the users life threating side affects then they would have had to sue the Pharmacy individually.
on June 4,2014 | 02:28PM
Anonymous wrote:
I would be very happy if they brought the price of advair down, $165 for 1 inhaler, for 1 month....shame on them.
on June 4,2014 | 10:39AM
Anonymous wrote:
They should of nailed them for 1000 fold.
on June 4,2014 | 10:40AM
Breaking News